The August Wellness Index Report, published by Wellness Eternal, focuses on the discipline that determines whether longevity science reaches anyone at all. The science of living longer means little until it reaches real people. Translational longevity is the work of closing that gap, and its leading voices converge this October at the Translational Longevity Summit in Boston, hosted by Boston BioLife and the Healthspan Action Coalition.
The report identifies three key signals: cell science moving from proof of concept to real clinical delivery, evidence emerging as the bridge from research to practice, and clinical strategy and systems proving essential to scaling care. These signals underscore the shift from laboratory breakthroughs to treatments that can reverse, rather than manage, the drivers of disease and aging.
Dr. Camillo Ricordi of the University of Miami anchors the report's first signal. As a distinguished professor and researcher, his work in transplantation and cell therapy exemplifies the movement of foundational science into clinical reality. Dr. David Barzilai, a Harvard Medical School lecturer and longevity medicine physician, represents the second signal. He is known for making complex scientific advances accessible and actionable for clinicians, executives, and policymakers, serving as medical editor of Harvard Health Publishing's Pathways to Longevity. Dr. Suzie Robertson, a clinical pharmacist and healthcare strategist at Matrix Biologics, embodies the third signal, bridging clinical excellence with innovation to improve patient safety and care delivery.
The report also highlights the summit's hosts: Joseph Krieger of Boston BioLife and Bernard Siegel of the Healthspan Action Coalition. Krieger has spent over 25 years streamlining translational medicine, while Siegel, a patient advocate and founder of the Healthspan Action Coalition, has been instrumental in the regenerative medicine ecosystem. The summit runs October 7 to 11 at the Harvard Enterprise Research Campus.
"The future of longevity is translational. The breakthroughs are real, but they only matter when they reach people," said Lindsay O'Neill-O'Keefe, Founder of Wellness Eternal. "Discovery is only half the job. Delivery is the rest."
The Wellness Index Report applies a four-step verification process built on expert nomination, customer and patient feedback, clinical review, and ongoing performance tracking. It is distributed across major media outlets, providing visibility to solutions that meet its integrity-first standard. For more insights, read the full report at wellnessindexreport.com.
